2013.10.26,我院温龙平教授研究组与印度化学技术研究所(CSIR-IICT)合作在Biomaterials上在线发的文章

时间:2021-04-12 21:20:01学院:生命科学学院学校:中国科学技术大学

2013.10.26,我院温龙平教授研究组与印度化学技术研究所(CSIR-IICT)合作在Biomaterials上在线发表题为“Accelerating the clearance of mutant huntingtin protein aggregates through autophagy induction by europium hydroxide nanorods”的论文
作者:魏鹏飞、张力、Susheel Kumar Nethi、Ayan Kumar Barui、林俊、周伟、沈艺、满娜、张云娇、许静、Chitta Ranjan Patra*和温龙平*
Abstract
Autophagy is one of the well-known pathways to accelerate the clearance of protein aggregates, which contributes to the therapy of neurodegenerative diseases. Although there are numerous reports that demonstrate the induction of autophagy with small molecules including rapamycin, trehalose and lithium, however, there are few reports mentioning the clearance of aggregate-prone proteins through autophagy induction by nanoparticles. In the present article, we have demonstrated that europium hydroxide [EuIII(OH)3] nanorods can reduce huntingtin protein aggregation (EGFP-tagged huntingtin protein with 74 polyQ repeats), responsible for neurodegenerative diseases. Again, we have found that these nanorods induce authentic autophagy flux in different cell lines (Neuro 2a, PC12 and HeLa cells) through the expression of higher levels of characteristic autophagy marker protein LC3-II and degradation of selective autophagy substrate/cargo receptor p62/SQSTM1. Furthermore, depression of protein aggregation clearance through the autophagy blockade has also been observed by using specific inhibitors (wortmannin and chloroquine), indicating that autophagy is involved in the degradation of huntingtin protein aggregation. Since [EuIII(OH)3] nanorods can enhance the degradation of huntingtin protein aggregation via autophagy induction, we strongly believe that these nanorods would be useful for the development of therapeutic treatment strategies for various neurodegenerative diseases in near future using nanomedicine approach.
 
http://dx.doi.org/10.1016/j.biomaterials.2013.10.024
 



版权与免责声明:本网页的内容由收集互联网上公开发布的信息整理获得。目的在于传递信息及分享,并不意味着赞同其观点或证实其真实性,也不构成其他建议。仅提供交流平台,不为其版权负责。如涉及侵权,请联系我们及时修改或删除。邮箱:sales@allpeptide.com

返回首页 浙公网安备 33010602009704号;浙ICP备18001318号